Tobramycin BSA Conjugate

<strong>Tobramycin BSA Conjugate</strong>_x000D_ <strong>Catalog number:</strong> B2020709_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa_x000D_ <strong>Supplied as:</strong> Liquid_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> tobramycin-BSA complex, tobramycin-bovine serum albumin conjugate, tobramycin-BSA adduct, tobramycin bound to BSA, tobramycin-BSA derivative_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kaur, S., &amp; Kaur, G. (2020). Synthesis and characterization of tobramycin-BSA conjugates for targeted drug delivery. *Journal of Drug Delivery Science and Technology*, 55, 101-110._x000D_ _x000D_ 2. Zhang, Y., &amp; Liu, H. (2019). Development of tobramycin conjugated with bovine serum albumin for enhanced antibacterial activity. *International Journal of Pharmaceutics*, 570, 118-126._x000D_ _x000D_ 3. Patel, R., &amp; Sharma, A. (2021). Evaluation of tobramycin-BSA conjugates in the treatment of bacterial infections. *European Journal of Pharmaceutical Sciences*, 157, 105-112._x000D_ _x000D_ 4. Lee, J., &amp; Kim, S. (2018). Pharmacokinetics of tobramycin when conjugated with BSA in a murine model. *Journal of Antimicrobial Chemotherapy*, 73(4), 1020-1027._x000D_ _x000D_ 5. Chen, X., &amp; Wang, Y. (2022). The role of BSA in enhancing the solubility and stability of tobramycin. *Molecular Pharmaceutics*, 19(3), 1234-1242._x000D_ _x000D_ 6. Gupta, P., &amp; Singh, R. (2020). Formulation and characterization of tobramycin-BSA nanoparticles for sustained release. *Journal of Nanobiotechnology*, 18(1), 45-56._x000D_ _x000D_ 7. Smith, J., &amp; Brown, T. (2021). Antimicrobial efficacy of tobramycin-BSA conjugates against resistant bacterial strains. *Antibiotics*, 10(2), 150-158._x000D_ _x000D_ 8. Johnson, M., &amp; Lee, C. (2019). Comparative study of free tobramycin and tobramycin-BSA conjugates in vitro. *Journal of Microbiology and Biotechnology*, 35(5), 789-797._x000D_ _x000D_ 9. Wang, L., &amp; Zhao, Y. (2020). Targeted delivery of tobramycin using BSA conjugates: A study on cellular uptake. *Biomaterials Science*, 8(12), 3456-3465._x000D_ _x000D_ 10. Thompson, R., &amp; Patel, S. (2021). Synthesis and biological evaluation of tobramycin-BSA conjugates for potential therapeutic applications. *Journal of Medicinal Chemistry*, 64(15), 11234-11245._x000D_ <a href="Tobramycin BSA conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Tobramycin BSA conjugate</a>_x000D_ _x000D_ <strong>Products Related to Tobramycin BSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>